Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PEP07 |
Synonyms | |
Therapy Description |
PEP07 inhibits checkpoint kinase 1 (Chk1), which may induce DNA damage, tumor cell killing, and antitumor activity (Cancer Res (2017) 77 (13_Supplement): 295). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PEP07 | PEP-07|PEP 07|CASC-578|CASC578|CASC 578|SOL-578|SOL578 | CHK1 Inhibitor 18 | PEP07 inhibits checkpoint kinase 1 (Chk1), which may induce DNA damage, tumor cell killing, and antitumor activity (Cancer Res (2017) 77 (13_Supplement): 295). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05659732 | Phase I | PEP07 | A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer | Recruiting | AUS | 1 |